![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Clears RevMedX’s Wound Dressing for Civilians
FDA Clears RevMedX’s Wound Dressing for Civilians
![](https://www.fdanews.com/ext/resources/test/Device_Images4/FDA_Logo_Large.gif?t=1486528488&width=430)
The FDA has given its blessing to RevMedX’s XSTAT 30 wound dressing to treat adults and adolescents in the general population.
The expandable, multi-sponge dressing – used to control life-threatening bleeding from wounds in areas that a tourniquet cannot be placed, such as the groin or armpit – was previously only cleared for military use.
It is indicated for patients at high risk for immediate, life-threatening and severe hemorrhagic shock and non-compressible junctional wounds when care at emergency rooms is not available within a few minutes.
The dressing is not designed for use in certain parts of the chest, abdomen, pelvis or tissue above the collarbone. — Michael Cipriano
Upcoming Events
-
21Oct